|
KIAA1632 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02210000019198E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.157800E-04 |
| Normal-vs-Stage2 |
5.91759999999386E-05 |
| Normal-vs-Stage3 |
2.43471909300297E-13 |
| Normal-vs-Stage4 |
2.781600E-04 |
| Stage1-vs-Stage2 |
2.008000E-01 |
| Stage1-vs-Stage3 |
4.60889999998049E-06 |
| Stage1-vs-Stage4 |
1.375420E-01 |
| Stage2-vs-Stage3 |
4.377600E-02 |
| Stage2-vs-Stage4 |
6.233200E-01 |
| Stage3-vs-Stage4 |
4.169800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1627999996211E-07 |
| Normal-vs-AfricanAmerican |
1.258810E-01 |
| Normal-vs-Asian |
5.432400E-01 |
| Caucasian-vs-AfricanAmerican |
2.635800E-01 |
| Caucasian-vs-Asian |
1.936230E-01 |
| AfricanAmerican-vs-Asian |
6.020200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90759963381026E-10 |
| Normal-vs-Female |
2.438600E-03 |
| Male-vs-Female |
1.769890E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.809600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.376700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.63540300693421E-11 |
| Normal-vs-Age(81-100Yrs) |
4.99330000003351E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.969200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.377000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.093400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.721700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.483900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.983600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.371600E-01 |
| Normal-vs-Grade 2 |
7.92090000000245E-05 |
| Normal-vs-Grade 3 |
9.38430000374524E-08 |
| Normal-vs-Grade 4 |
4.8997472745782E-12 |
| Grade 1-vs-Grade 2 |
1.444190E-01 |
| Grade 1-vs-Grade 3 |
8.803800E-02 |
| Grade 1-vs-Grade 4 |
3.997700E-02 |
| Grade 2-vs-Grade 3 |
5.025600E-02 |
| Grade 2-vs-Grade 4 |
4.3602000000531E-06 |
| Grade 3-vs-Grade 4 |
1.338290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.40029999999792E-05 |
| Normal-vs-ccB subtype |
2.21599999461475E-08 |
| ccA subtype-vs-ccB subtype |
3.276500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35609999954534E-07 |
| Normal-vs-N1 |
6.301100E-03 |
| N0-vs-N1 |
7.433000E-01 |
|
|
